Intrapleural Hyaluronidase in Viscous Malignant Mesothelioma Pleural Effusion.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 34872672.
- Also identified by DOI 10.1016/j.chest.2021.07.031.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Malignant pleural effusion is common in mesothelioma. We report a case of viscous recurrent malignant mesothelioma pleural effusion. The viscosity was due to the presence of hyaluronic acid and resulted in prolonged drainage time. The use of intrapleural hyaluronidase significantly reduced fluid viscosity and drainage duration. No adverse reactions were noted. This novel case highlights the feasibility and safety of the use of intrapleural hyaluronidase in the management of hyaluronic acid-rich viscous malignant pleural effusion.
Medical subject headings
- Exudates and Transudates
- Hyaluronoglucosaminidase
- Mesothelioma, Malignant
- Pleural Effusion, Malignant
- Pleural Neoplasms